Precede Biosciences Presents New ESMO 2025 Data Demonstrating Its Liquid Biopsy Platforms Ability to Resolve Target Expression and Molecular Subtypes in Small Cell Lung Cancer
Small cell lung cancer (SCLC) accounts for 15% of all lung cancers…
Roche presents new phase III pivotal data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
Vamikibart is the first non-steroid targeted therapy designed to address inflammation driving…
IIFL Capital Presents JITO Connect 2025: Celebrating Entrepreneurship, Innovation, and Community Leadership
IIFL Capital ( www.iiflcapital.com/hni-wealth), one of India’s leading wealth management firms, has…
SKEMA presents UNVEIL, its 2025 – 2030 strategic plan
To unveil talents and transform societies PARIS, Oct. 9, 2025 /PRNewswire/ --…
Artprice News: ahead of Frieze London and Art Basel Paris, Artprice by Artmarket releases its 2025 Contemporary Art Market Report. Annual record number of auction transactions, substantial market paradigm shift, AI influences
PARIS, Oct. 7, 2025 /PRNewswire/ -- With Frieze London about to kick…
Kolmar Korea Presents “K-Beauty Success Roadmap” in Amazon Beauty in Seoul
Official manufacturing sponsor of Amazon Beauty in Seoul 2025, attracting over 3,000…
TANISHQ WELCOMES CUSTOMERS TO ITS LATEST STORE IN SKY CITY MALL, BORIVALI
MUMBAI, India, Sept. 30, 2025 /PRNewswire/ -- Tanishq, India's largest jewellery retail…
AEG and Tractor Beverage Company Take Center Stage With First-of-Its-Kind Partnership Bringing Certified Organic Craft Haymaker Tonics to Live Music Venues Nationwide
Multiyear Partnership Expands Tractor’s Reach Across Live Entertainment with Exclusive Launch of…
CGTN AMERICA & CCTV UN: “Beauty in Harmony, Destiny in Unity” Visual Works Exhibition
WASHINGTON, Sept. 22, 2025 /PRNewswire/ -- CGTN America & CCTV UN releases…
C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting Potential Best-in-Class Profile at the International Myeloma Society Annual Meeting
September 20, 2025 11:00 ET Â | Source: C4 Therapeutics, Inc. Cemsidomide in…